PROTAC technology service platform: a full chain solution from molecular design to preclinical research
In recent years, Proteolysis-Targeting Chimeras (PROTAC) has become a frontier in the field of chemical biology and drug discovery by its unique event-driven mechanism of action, which breaks through the dependence of traditional small-molecule inhibitors on the “druggable target”. It…